48,874
edits
Line 2: | Line 2: | ||
Kidney tumours with TSC/mTOR mutations: | Kidney tumours with TSC/mTOR mutations: | ||
*[[Renal cell carcinoma with fibromyomatous stroma]].<ref name=pmid37899532>{{cite journal |authors=Shah RB, Mehra R |title=Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up |journal=Adv Anat Pathol |volume=31 |issue=2 |pages=105–117 |date=March 2024 |pmid=37899532 |doi=10.1097/PAP.0000000000000419 |url=}}</ref> | |||
*[[Eosinophilic solid and cystic renal cell carcinoma]].<ref name=pmid35203531>{{cite journal |authors=Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O |title=TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background |journal=Biomedicines |volume=10 |issue=2 |pages= |date=January 2022 |pmid=35203531 |pmc=8869370 |doi=10.3390/biomedicines10020322 |url=}}</ref> | *[[Eosinophilic solid and cystic renal cell carcinoma]].<ref name=pmid35203531>{{cite journal |authors=Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O |title=TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background |journal=Biomedicines |volume=10 |issue=2 |pages= |date=January 2022 |pmid=35203531 |pmc=8869370 |doi=10.3390/biomedicines10020322 |url=}}</ref> | ||
*[[Eosinophilic vacuolated tumour]].<ref name=pmid35203531/> | *[[Eosinophilic vacuolated tumour]].<ref name=pmid35203531/> | ||
*[[Low-grade oncocytic tumour]].<ref name=pmid35203531/> | *[[Low-grade oncocytic tumour]].<ref name=pmid35203531/> | ||
==References== | ==References== |
edits